Home › Funds › Patient Capital Management, LLC › BIIB
Patient Capital Management, LLC position in BIIB
BIOGEN INC · Health Care
Patient Capital Management, LLC reported holding 189,400 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$42.8M, representing 1.45% of its reported portfolio and ranking #25 among its reported holdings. Patient Capital Management, LLC has disclosed BIIB holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Patient Capital Management, LLC's BIIB position evolved
Patient Capital Management, LLC first disclosed a stake in BIIB in Q1 2024 at 217,887 shares (US$47.0M). The position peaked in Q4 2025 at 576,352 shares, worth US$101.4M. Across 11 filings, Patient Capital Management, LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 189,400 shares valued at US$42.8M. Notable position changes include a 62% increase in Q4 2024 (shares fell 11% over the following quarter), a 100% trim in Q1 2026 (shares rose 18% over the following quarter), a 9900% increase in Q2 2026 (shares rose 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 217.89K | $46.98M | New |
| Q2 2024 | 257.27K | $59.64M | Add |
| Q3 2024 | 255.94K | $49.61M | Reduce |
| Q4 2024 | 413.96K | $63.30M | Add |
| Q1 2025 | 455.61K | $62.35M | Add |
| Q2 2025 | 320.47K | $40.25M | Reduce |
| Q3 2025 | 396.65K | $55.56M | Add |
| Q4 2025 | 576.35K | $101.43M | Add |
| Q1 2026 | 1.89K | $34.72M | Reduce |
| Q2 2026 | 189.40K | $40.92M | Add |
| Q3 2026 | 189.40K | $42.78M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIIB and 13F data
BIIB (BIOGEN INC) is a Health Care company. 20 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.43B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIIB
- PRIMECAP MANAGEMENT CO/CA/ 15.20M sh · $3.43B · Q3 2026
More on Patient Capital Management, LLC
FAQ
How long has Patient Capital Management, LLC held BIIB?
Patient Capital Management, LLC has disclosed BIIB holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Patient Capital Management, LLC's current position in BIIB?
As of Q3 2026, Patient Capital Management, LLC holds 189.40K shares of BIIB (BIOGEN INC), valued at $42.78M, representing 1.45% of its reported portfolio and ranking #25.
Has Patient Capital Management, LLC been buying or selling BIIB?
In the latest 13F filing (Q3 2026), Patient Capital Management, LLC held unchanged its position in BIIB. The position peaked in Q4 2025 at 576.35K shares.
Which other funds hold BIIB?
Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.